Targovax ASA (TRVX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
29 Pages - GLDATA58302
$250.00

Summary

Targovax ASA (Targovax) is a clinical stage immuno-oncology company that focuses on the design and development of treatments for cancer patients. Among the company’s lead candidates, TG01 is a peptide-based therapeutic anti-cancer vaccine under development for pancreatic cancer; and ONCOS-102 is an adenovirus-based pipeline product for solid tumor indications. Its product pipeline also includes TG02, TG03, ONCOS-402, ONCOS-802 and ONCOS-902 for other cancer indications. Targovax develops immunotherapies based on two approaches harnessing the patient’s immune system to target cancer; a virus-based immunotherapy platform based on engineered oncolytic viruses for solid tumors and a peptide-based immunotherapy platform for RAS-mutated cancers. The company operates a subsidiary in Helsinki, Finland. Targovax is headquartered in Oslo, Norway.

Targovax ASA (TRVX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Targovax ASA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 4
Targovax ASA, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Targovax ASA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Targovax ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Targovax ASA, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Targovax ASA, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Targovax Raises US$1.3 Million In Venture Financing 10
Targovax Raises US$2.2 Million In Series A Financing 12
Targovax Raises Additional US$1 Million In Venture Financing 14
Oncos Therapeutics Raises US$5.5 Million In Venture Financing 15
Partnerships 16
Targovax Enters into Agreement with Sotio 16
Ludwig Institute for Cancer Research and Cancer Research Institute Partner with Targovax 17
Merger 18
Oncos Therapeutics Completes Merger with Targovax 18
Equity Offering 19
Targovax Raises USD0.5 Million in IPO 19
Targovax Raises USD13.3 Million in Private Placement of Shares 21
Targovax Raises USD26 Million in Private Placement of Shares 23
Targovax Raises USD11.6 Million through Shares Issue 25
Targovax ASA - Key Competitors 26
Key Employees 27
Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Targovax ASA, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Targovax ASA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Targovax ASA, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Targovax ASA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Targovax ASA, Deals By Therapy Area, 2010 to YTD 2016 8
Targovax ASA, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Targovax Raises US$1.3 Million In Venture Financing 10
Targovax Raises US$2.2 Million In Series A Financing 12
Targovax Raises Additional US$1 Million In Venture Financing 14
Oncos Therapeutics Raises US$5.5 Million In Venture Financing 15
Targovax Enters into Agreement with Sotio 16
Ludwig Institute for Cancer Research and Cancer Research Institute Partner with Targovax 17
Oncos Therapeutics Completes Merger with Targovax 18
Targovax Raises USD0.5 Million in IPO 19
Targovax Raises USD13.3 Million in Private Placement of Shares 21
Targovax Raises USD26 Million in Private Placement of Shares 23
Targovax Raises USD11.6 Million through Shares Issue 25
Targovax ASA, Key Competitors 26
Targovax ASA, Key Employees 27
Targovax ASA, Subsidiaries 28

List of Figures
Targovax ASA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Targovax ASA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Targovax ASA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Targovax ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Targovax ASA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Targovax ASA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Targovax ASA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Targovax ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838